InvestorsHub Logo
Followers 5
Posts 113
Boards Moderated 0
Alias Born 01/19/2015

Re: None

Monday, 05/25/2020 10:06:00 AM

Monday, May 25, 2020 10:06:00 AM

Post# of 232145
Comparison David (Cytodyn) against Goliath (Gilead)
Fox News:
https://www.foxnews.com/science/biotech-covid-19-treatment-trial-combining-experimental-coronavirus-drugs-leronlimab-remdesivir

According to the results of the study, Remdesevir brings almost no improvement in Covid-19 patients!

Remdesevir on NEJM - extract:
Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), none have yet been shown to be efficacious.
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

CNN report:
https://edition.cnn.com/2020/05/22/health/remdesivir-covid-19-trial-results-nejm-study/index.html

Zerohedge report:
https://www.zerohedge.com/technology/remdesivir-study-finally-out-drug-only-helped-those-oxygen-finds-mortality-too-high

The results of Leronlimab study will probably bring even more advantages for Cytodyn!



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News